MMP-10/stromelysin-2 promotes invasion of head and neck cancer

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Deraz, Elsayed Mohamed ^a   Kudo, Yasusei ^a   Yoshida, Maki ^a   Obayashi, Mariko ^a   Tsunematsu, Takaaki ^a   Tani, Hirotaka ^a   Siriwardena, Samadarani B S M ^a   Kiekhaee, Mohammad Reza ^a   Qi, Guangying ^a   Iizuka, Shinji ^a   Ogawa, Ikuko ^b   Campisi, Giuseppina ^c   Muzio, Lorenzo Lo ^d   Abiko, Yoshimitsu ^e   Kikuchi, Akira ^f   Takata, Takashi ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF PALERMO   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e NIHON UNIVERSITY   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN IFITM1; SMALL INTERFERING RNA; STROMELYSIN 2; TRANSCRIPTION FACTOR RUNX2; TUMOR MARKER; UNCLASSIFIED DRUG; WNT5B PROTEIN; CELL ADHESION MOLECULE; DIFFERENTIATION ANTIGEN; LEU 13 ANTIGEN; LEU-13 ANTIGEN; POSTN PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; WNT PROTEIN; WNT5B PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MATRIX METALLOPROTEINASE 13 GENE; METASTASIS; MICROARRAY ANALYSIS; ONCOGENE; PREDICTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; STROMELYSIN 2 GENE; DRUG ANTAGONISM; DRUG EFFECT; EXTRACELLULAR MATRIX; GENETICS; HEAD AND NECK TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

MOUSE MAMMARY TUMOR VIRUS;

ANTIGENS, DIFFERENTIATION; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; MATRIX METALLOPROTEINASE 10; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; UP-REGULATION; WNT PROTEINS;

EID: 80053608041     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025438     Document Type: Article

References (45)

1. Mao L, Hong WK, Papadimitrakopoulou VA, (2004) Focus on head and neck cancer. Cancer Cell 5: 311-316.
2. Neville BW, Damm DD, Allen CM, Bouquot JE, (1995) Epithelial Pthology. Oral and Maxillofacial Pathology. Edited by Neville BW. Philadelphia, W B Saunders 295-302.
3. Mamelle G, Pampurik J, Luboinski B, Lancer R, Lusinchi A, et al. (1994) Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 168: 494-498.
4. Fidler IJ, (1990) Critical factors in the biology of human cancer metastasis: Twenty-eighth GHA Clowes Memorial Award Lecture. Cancer Res 50: 6130-6138.
5. Howell GMS, Grandis JR, (2005) Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck 27: 710-717.
6. Kudo Y, Kitajima S, Sato S, Ogawa I, Miyauchi M, et al. (2003) Establishment of an oral squamous cell carcinoma cell line with high invasive and p27 degradation activity from lymph node metastasis. Oral Oncol 39: 515-520.
7. Kudo Y, Kitajima S, Ogawa I, Hiraoka M, Salgolzaei S, et al. (2004) Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous ß-catenin. Clin Cancer Res 10: 5455-5463.
8. Kudo Y, Ogawa I, Kitajima S, Kitagawa M, Kawai H, et al. (2006) Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res 66: 6928-6935.
9. Hatano H, Kudo Y, Ogawa I, Tsunematsu T, Kikuchi A, et al. (2008) IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression. Clin Cancer Res 14: 6097-6105.
10. Milner JM, Cawston TE, (2005) Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases. Curr Drug Targets Inflamm Allergy 4: 363-375.
11. Werner JA, Rathcke IO, Mandic R, (2002) The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 19: 275-282.
12. Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, et al. (1999) Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of oral cavity: correlations with tumor invasion and metastasis. Head Neck 21: 627-638.
13. Kawata R, Shimada T, Maruyama S, Hisa Y, Takenaka H, et al. (2002) Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis. Acta Otolaryngol 122: 101-106.
14. Jacobsson PA, Eneroth GM, Killander D, Moberger G, Martensson B, (1973) Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol 12: 1-7.
15. Japan Society for Head and Neck Cancer. (2005) General Rules for Clinical and Pathological Studies on Head and Neck Cancer, 4th Edition. Kanehara Tokyo.
16. Saitoh T, Katoh M, (2002) Expression and regulation of WNT5A and WNT5B in human cancer: up-regulation of WNT5A by TNFalpha in MKN45 cells and up-regulation of WNT5B by beta-estradiol in MCF-7 cells. Int J Mol Med 10: 345-349.
17. Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, et al. (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1: 279-288.
18. Pukrop T, Klemm F, Hagemann T, Gradl D, Schulz M, et al. (2006) Wnt5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. Proc Natl Acad Sci U S A 103: 5454-5459.
19. Kurayoshi M, Oue N, Yamamoto H, Kishida M, Inoue A, et al. (2006) Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 66: 10439-10448.
20. Ripka S, König A, Buchholz M, Wagner M, Sipos B, et al. (2007) WNT5A--target of CUTL1 and potent modulator of tumor cell migration and invasion in pancreatic cancer. Carcinogenesis 28: 1178-1187.
21. Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, et al. (2009) Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogene 28: 3197-3208.
22. Yamamoto H, Kitadai Y, Yamamoto H, Oue N, Ohdan H, et al. (2009) Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells. Gastroenterology 137: 242-252.
23. Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, et al. (2010) Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 29: 2036-2046.
24. Stocker IV, Grams F, Baumann U, (1995) The metzincins-topological and sequential relations between the astacins, adamalysins, serralysins, and the matrixins (collagenases) define a superfamily of zinc-peptides. Protein Sci 4: 823-840.
25. Nagase H, Woessner JF, (1999) Matrix metalloproteinases. J Biol Chem 274: 21491-21494.
26. Seiki M, (1999) Membrane-type matrix metalloproteinases. APMIS 107: 137-143.
27. Frederick LA, Matthews JA, Jamieson L, Justilien V, Thompson EA, et al. (2008) Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer. Oncogene 27: 4841-4853.
28. Gill JH, Kirwan IG, Seargent JM, Martin SW, Tijani S, et al. (2004) MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas. Neoplasia 6: 777-785.
29. Sirum K, Brinckerhoff CE, (1989) Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts. Biochemistry 28: 8691-8698.
30. Saarialho-Kere UK, Pentland AP, Birkedal-Hansen H, Parks WC, Welgus HG, (1994) Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 94: 79-88.
31. Windsor LJ, Grenett H, Birkedal-Hansen B, Bodden MK, Engler JA, et al. (1993) Cell type-specific regulation of SL-1 and SL-2 genes. J Biol Chem 268: 17341-17347.
32. Madlener M, Werner S, (1997) cDNA cloning and expression of the gene encoding murine stromelysin-2 (MMP10). Gene 202: 75-81.
33. Sternlicht MD, Bissell MJ, Werb Z, (2000) The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19: 1102-1113.
34. Van Themsche C, Alain T, Kossakowska AE, Urbanski S, Potworowski EF, et al. (2004) Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo. J Immunol 173: 3605-3611.
35. Ye H, Yu T, Temam S, Ziober BL, Wang J, et al. (2008) Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 9: 69-79.
36. Yen CY, Chen CH, Chang CH, Tseng HF, Liu SY, et al. (2009) Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers. Biomarkers 14: 244-249.
37. Kudo Y, Siriwardena BSMS, Hatano H, Ogawa I, Takata T, (2007) Periostin: Novel diagnostic and therapeutic target for cancer. Histol Histopathol 22: 1167-1174.
38. Siriwardena BSMS, Kudo Y, Ogawa I, Kitagawa M, Kitajima S, et al. (2006) Periostin is frequently overexpressed and enhances invasion and angiogenesis in oral cancer. Br J Cancer 95: 1396-1403.
39. Han X, Bolcato AL, Amar S, (2002) Identification of genes differentially expressed in cultured human osteoblasts versus human fibroblasts by DNA microarray analysis. Connect Tissue Res 43: 63-75.
40. Barkebusch C, Bouvard D, Stanchi F, Saki T, Fassler R, (2002) Integrins in invasive growth. J Clin Invest 109: 999-1006.
41. Dissanayake SK, Wade M, Johnson CE, O'Connell MP, Leotlela PD, et al. (2007) The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 282: 17259-17271.
42. Masckauchán TN, Agalliu D, Vorontchikhina M, Ahn A, Parmalee NL, et al. (2006) Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell 17: 5163-5172.
43. Ishikawa F, Miyoshi H, Nose K, Shibanuma M, (2010) Transcriptional induction of MMP-10 by TGF-β, mediated by activation of MEF2A and downregulation of class IIa HDACs. Oncogene 29: 909-919.
44. Chen RS, Song YM, Zhou ZY, Tong T, Li Y, et al. (2009) Disruption of xCT inhibits cancer cell metastasis via the caveolin-1β-catenin pathway. Oncogene 28: 599-609.
45. Hickson JA, Huo D, Vander Griend DJ, Lin A, Rinker-Schaeffer CW, et al. (2006) The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. Cancer Res 66: 2264-2270.